-
龚学忠：新冠肺炎合并急性肾损伤
2020-04-28 31235 看过 免费 -
第一期：新形势下的肿瘤合理用药管理
话题一：从政策更新谈肿瘤合理用药的管理话题二：解读2019版新型抗肿瘤药物临床应用指导原则话题三：免疫治疗合理用药的挑战和解决之道
2020-04-28 26339 看过 免费 -
【关爱肾脏，合理用药】线上会议
2020-04-28 37612 看过 免费 -
悉听我说 第四期
2020-04-27 25416 看过 免费 -
悉听我说 第三期
狼疮性肾炎规范化诊疗的探讨
2020-04-25 27283 看过 免费 -
悉听我说第二期
2020-04-24 26065 看过 免费 -
第六期 中西医结合疾病管理“心”模式
2020-04-23 51086 看过 免费 -
空中对话系列|第三期
协办单位：中国医学论坛报社
2020-04-23 25402 看过 免费 -
CMT introudctions
China Medical Tribune was founded in 1983. It is a professional medical media co-founded by the former Ministry of Health and Sackler Foundation. It is a public institution under the Center for International Exchange and Cooperation, National Health Commission. CMT adheres to the spirit of dedication, innovation and responsibility. It is committed to conveying the advances and attracting fields of studies in medical science and clinical practice at home and abroad to 2 million Chinese doctors in the principle of evidence-based reporting methods; and it also provides the latest medical information and solutions to clinical problems. CMT listens to different academic voices and delivers objective medical information to Chinese clinical workers. It is currently one of the largest and most influential professional medical newspaper in China. In addition to the newspaper business, it also covers the scope of online media platforms, including its one and only official medical education-based application CMTopDr, the matrix of wechat public accounts and customized platforms for live conference broadcasting, surveys and collection of real-world medical records.
2020-04-23 14055 看过 免费 -
悉听我说第一期
2020-04-22 26975 看过 免费
直播预告
热门资讯
- 全球品质，本地供应——舒万诺首款国产光固化复合树脂获证上市，加速中国口腔健康服务升级
- 五季同行，如期赴约！第五季跟着“国家队”学常见疾病诊疗诚意回归！
- 破CRE耐药困局，“天下无酶” 引航—— 耐药菌感染多学科诊疗学术论坛在北京成功举办
- 精准治疗：氨曲南/阿维巴坦如何改变CRE治疗路径
- 高凌云教授深度解析FIBRONEER系列研究，nerandomilast为抗纤维化治疗提供安全性新范式
- 高达标，高治愈：氨曲南-阿维巴坦PK/PD达标率>90%，实现有效治疗
- 全周期护航，科技启新章——2025脑健康大会在京成功举办
- 基础胰岛素：何时启动？如何选择与调整？
- “说”出你的心声！——中国医师节【初心如磐，微光致远】活动来了！听你们的......
- 超越二甲双胍——个体化降糖治疗新选择
